Supplementary Table 1 from Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
| Autor: | Douglas Hanahan, Ian B. Walters, Elizabeth Allen |
|---|---|
| Rok vydání: | 2023 |
| DOI: | 10.1158/1078-0432.22443000 |
| Popis: | PDF file - 60K |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|